Credit card spending in India moderated in January to Rs 1.99 lakh crore, down from December’s festival-led high but up over 8% year-on-year. This indicates a normalization of growth after a festive surge, with active card numbers rising to 116.6 million, though new additions slowed due to tighter underwriting and regulatory caution.
Liraglutide still a ‘decent market’ despite Novo’s price moves: Siddharth Mittal, Biocon
Biocon CEO Siddharth Mittal outlines the company’s strategy in the competitive GLP-1 market. Focusing on liraglutide’s launch in the US and Europe, he highlights opportunities